4//SEC Filing
Congleton Jon 4
Accession 0001933414-24-000029
CIK 0001933414other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:15 PM ET
Size
8.6 KB
Accession
0001933414-24-000029
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-06-12$12.77/sh−16,607$212,013→ 1,032,461 total - Sale
Common Stock
2024-06-13$12.74/sh−39,961$509,027→ 992,500 total - Sale
Common Stock
2024-06-14$12.52/sh−16,229$203,163→ 976,271 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.4587 to $13.35. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.49 to $13.04.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.635.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001644975
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:15 PM ET
- Size
- 8.6 KB